Quality assessment of clinical guidelines in China: 1993 - 2010.

Abstract

Compared with other studies on the quality of guidelines assessed with the AGREE instrument in other countries, Chinese CPGs received lower scores, which indicates a relatively poor quality of the guidelines. However, there was some increase over time.